Bruton's Tyrosine Kinase Inhibition in Pemphigus: An Embattled Frontier

被引：1
|
作者：
Payne, Aimee S. [1 ]
Vieira, Silvio Manfredo [2 ]
机构：
[1] Columbia Univ, Vagelos Coll Phys & Surg, Dept Dermatol, New York, NY 10032 USA
[2] Univ Penn, Perelman Sch Med, Dept Dermatol, Philadelphia, PA USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2024年 / 144卷 / 08期
关键词：
D O I：
10.1016/j.jid.2024.03.014
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1667 / 1670
页数：4
相关论文
共 50 条
  • [21] Computational Investigation of the Covalent Inhibition Mechanism of Bruton's Tyrosine Kinase by Ibrutinib
    Barragan, Angela M.
    Ghaby, Kyle
    Pond, Matthew P.
    Roux, Benoit
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2024, 64 (08) : 3488 - 3502
  • [22] A phase II study of Bruton's tyrosine kinase inhibition for the prevention of anaphylaxis
    Suresh, Ragha, V
    Dunnam, Collin
    Vaidya, Dhananjay
    Wood, Robert A.
    Bochner, Bruce S.
    MacGlashan Jr, Donald W.
    Dispenza, Melanie C.
    JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (16):
  • [23] Bruton’s Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease
    Stefan F. H. Neys
    Jasper Rip
    Rudi W. Hendriks
    Odilia B. J. Corneth
    Drugs, 2021, 81 : 1605 - 1626
  • [24] Bruton's Tyrosine Kinase Inhibition in the Treatment of Preclinical Models and Multiple Sclerosis
    Steinmaurer, Anja
    Wimmer, Isabella
    Berger, Thomas
    Rommer, Paulus S.
    Sellner, Johann
    CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (06) : 437 - 444
  • [25] Bruton's Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease
    Neys, Stefan F. H.
    Rip, Jasper
    Hendriks, Rudi W.
    Corneth, Odilia B. J.
    DRUGS, 2021, 81 (14) : 1605 - 1626
  • [26] Inhibition of Bruton's tyrosine kinase as a novel therapeutic approach in multiple sclerosis
    Torke, Sebastian
    Weber, Martin S.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (10) : 1143 - 1150
  • [27] BRUTON'S TYROSINE KINASE INHIBITION TO SUPPRESS MAST CELL ACTIVATION IN ATHEROSCLEROSIS
    Hemme, E.
    Delfos, L.
    Depuydt, M. A. C.
    Kleijn, M. N. A. Bernabe
    Schaftenaar, F. H.
    Foks, A. C.
    Kuiper, J.
    Bot, I.
    ATHEROSCLEROSIS, 2022, 355 : E100 - E100
  • [28] Efficacy of a Bruton's Tyrosine Kinase Inhibitor (PRN-473) in the treatment of canine pemphigus foliaceus
    Goodale, Elizabeth C.
    Varjonen, Katarina E.
    Outerbridge, Catherine A.
    Bizikova, Petra
    Borjesson, Dori
    Murrell, Dedee F.
    Bisconte, Angelina
    Francesco, Michelle
    Hill, Ronald J.
    Masjedizadeh, Mohammad
    Nunn, Philip
    Gourlay, Steven G.
    White, Stephen D.
    VETERINARY DERMATOLOGY, 2020, 31 (04) : 291 - +
  • [29] Bruton's Tyrosine Kinase in Ankylosing Spondylitis
    Liao, Hsien-Tzung
    Chen, Chun-Hsiung
    SPINE, 2024, 49 (10) : 677 - 681
  • [30] Targeting Bruton's Tyrosine Kinase in CLL
    Ahn, Inhye E.
    Brown, Jennifer R.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
12345